Lastacaft
Active Ingredient(s): AlcaftadineFDA Approved: * July 28, 2010
Pharm Company: * VISTAKON PHARMA
Category: Vision / Eye Health
Alcaftadine is used to prevent eye irritation brought on by allergic conjunctivitis. It is a H1 histamine receptor antagonist.[2] It was approved by the U.S. Food and Drug Administration (FDA) in July 2010, under the trade name Lastacaft.[3] Contents 1 Pharmacology 2 Clinical relevance 3 Adverse effects 4 Pharmacokinetics 5 Sales 6 See also 7 References 8 External links Pharmacology Alcaftadine is an antagonist at three of the histamine receptors (1, 2 a... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.